Home Crystal structure of tetrachlorido-bis(1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2 N:N′)dicopper, C36H32Cu2N24Cl4
Article Open Access

Crystal structure of tetrachlorido-bis(1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2 N:N′)dicopper, C36H32Cu2N24Cl4

  • Tongyu Bai , Hanbing Li ORCID logo EMAIL logo , Mengmeng Cao and Xia Wang ORCID logo
Published/Copyright: October 21, 2024
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 239 Issue 6

Abstract

C36H32Cu2N24Cl4, monoclinic, P21/c (no. 14), a = 17.6099(4) Å, b = 8.13871(18) Å, c = 14.8084(3) Å, β = 91.6878(19)°, Z = 2, V = 2,121.45(8) Å3, R gt(F) = 0.0549, wR ref(F 2) = 0.1597, T = 293(2) K.

CCDC no.: 2388714

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Blue block
Size: 0.13 × 0.08 × 0.06 mm
Wavelength: Cu Kα radiation (1.54184 Å)
μ: 4.08 mm−1
Diffractometer, scan mode: Xcalibur, ω
θ max, completeness: 67.1°, >99 %
N(hkl)measured, N(hkl)unique, R int: 8,031, 3,769, 0.034
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 3,160
N(param)refined: 298
Programs: SHELX 1
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
Cu1 0.19753 (3) 0.64048 (7) 0.64603 (4) 0.0310 (2)
Cl1 0.20960 (6) 0.81935 (15) 0.76245 (8) 0.0437 (3)
Cl2 0.24586 (7) 0.42454 (14) 0.73346 (7) 0.0434 (3)
N1 0.08430 (18) 0.7260 (4) 0.6247 (2) 0.0305 (7)
N2 0.02879 (18) 0.6251 (4) 0.6407 (2) 0.0306 (7)
N3 −0.03507 (18) 0.7139 (4) 0.6471 (2) 0.0303 (7)
N4 −0.15391 (18) 0.6137 (4) 0.5855 (2) 0.0270 (7)
N5 −0.13698 (18) 0.5005 (4) 0.5235 (2) 0.0288 (7)
N6 −0.18991 (18) 0.5129 (4) 0.4601 (2) 0.0288 (7)
N7 0.26887 (19) 0.7982 (5) 0.5644 (2) 0.0341 (8)
N8 0.2903 (2) 0.7499 (4) 0.4841 (2) 0.0351 (8)
N9 0.33781 (19) 0.8650 (4) 0.4546 (3) 0.0352 (8)
N10 0.4401 (2) 0.7374 (5) 0.3791 (3) 0.0375 (8)
N11 0.5078 (2) 0.8006 (6) 0.4077 (3) 0.0502 (10)
N12 0.5580 (2) 0.6844 (6) 0.4107 (3) 0.0509 (11)
C1 0.0913 (3) 1.0357 (6) 0.6048 (3) 0.0384 (10)
H1 0.1431 1.0430 0.5950 0.046*
C2 0.0468 (3) 1.1714 (6) 0.6048 (3) 0.0443 (11)
H2 0.0686 1.2734 0.5941 0.053*
C3 −0.0317 (3) 1.1624 (6) 0.6206 (3) 0.0434 (11)
H3 −0.0600 1.2589 0.6204 0.052*
C4 −0.0673 (2) 1.0172 (6) 0.6360 (3) 0.0365 (9)
H4 −0.1191 1.0112 0.6464 0.044*
C5 −0.0213 (2) 0.8776 (5) 0.6352 (3) 0.0292 (8)
C6 0.0565 (2) 0.8838 (5) 0.6203 (3) 0.0292 (8)
C7 −0.1059 (2) 0.6311 (5) 0.6665 (3) 0.0301 (8)
H7A −0.1328 0.6934 0.7113 0.036*
H7B −0.0948 0.5232 0.6914 0.036*
C8 −0.2176 (2) 0.6951 (6) 0.5618 (3) 0.0355 (9)
H8 −0.2410 0.7780 0.5941 0.043*
C9 −0.2406 (2) 0.6316 (6) 0.4812 (3) 0.0386 (10)
H9 −0.2831 0.6632 0.4468 0.046*
C10 0.3027 (3) 0.9432 (6) 0.5850 (4) 0.0427 (11)
H10 0.2968 1.0028 0.6379 0.051*
C11 0.3470 (3) 0.9870 (6) 0.5149 (4) 0.0436 (11)
H11 0.3768 1.0806 0.5100 0.052*
C12 0.3746 (3) 0.8408 (6) 0.3690 (3) 0.0398 (10)
H12A 0.3388 0.7914 0.3260 0.048*
H12B 0.3897 0.9465 0.3451 0.048*
C13 0.4466 (2) 0.5737 (6) 0.3622 (3) 0.0342 (9)
C14 0.5229 (3) 0.5395 (7) 0.3831 (3) 0.0432 (11)
C15 0.5518 (3) 0.3799 (7) 0.3715 (4) 0.0528 (13)
H15 0.6025 0.3551 0.3844 0.063*
C16 0.5017 (3) 0.2633 (7) 0.3405 (4) 0.0573 (14)
H16 0.5188 0.1562 0.3330 0.069*
C17 0.4252 (3) 0.3000 (7) 0.3195 (4) 0.0541 (13)
H17 0.3936 0.2168 0.2975 0.065*
C18 0.3956 (3) 0.4541 (6) 0.3305 (3) 0.0426 (11)
H18 0.3447 0.4775 0.3176 0.051*

1 Source of materials

All starting materials are commercially available without further purification. 1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole (tmbt) was prepared according to the literature method with some modifications. 2 The ligand 1-[(1H-triazole-1-yl)methyl]-1H–benzotriazole (0.03 mmol, 0.0060 g) was dissolved in 2 mL of methanol solution and the solution was slowly add to 2 mL of CuCl2 (0.06 mmol, 0.0103 g) of methanol solution. The prepared solution was placed at room temperature and blue crystals were obtained after eight days.

2 Experimental details

H atoms were generated geometrically and refined as riding atoms with C–H = 0.93 Å and the and U iso(H) = 1.2 times U eq(C) for aromatic H atoms, with C–H = 0.97 Å and U iso(H) = 1.2 times U eq(C) for methylene H atoms.

3 Comment

Heterocyclic compounds, as a class of organic compounds, have been widely concerned by researchers because of their properties. For example, the isatin heterocyclic compounds synthesized by the Altamimi, M team have anti-cancer and antibacterial properties. 3 The heterocyclic compounds studied by Zhou M’s team can be applied as fluorescent anticancer drugs, 4 and the robust leishmanicidal upshot of some new diphenyl triazine-based molecules synthesized by Singh A’s team. 5 Among them, benzotriazole and triazole compounds, as nitrogen heterocyclic thick ring compounds, have abundant electrons and can be coordinated with transition metals to synthesize metal complexes with stable structure and different properties. And widely used in medicine fields. For example, Ricardo A Murcia-Galan’s team synthesized Co(II) and Cu(II) complexes containing 1,3-bis(benzotriazol-1-yl)-propan-2-ol and studied their antibacterial activities. 6 Czylkowska and Agnieszka synthesized five metal complexes from triazole derivatives, and found that the anticancer activity of the synthesized metal complexes was significantly stronger than that of the ligands. 7 Zhao Wanling and colleagues studied the synthesis of 7,8-dihydroxyflavone-copper metal complex (CAM–DHF) from flavonoid compounds such as 7,8-dihydroxyflavone found in traditional Chinese medicine and other natural medicines with copper ions. The formation of the complex with flavonoids can reduce the reproductive toxicity of copper ions, and it is speculated to have good biosafety. 8

X-ray crystallographic analysis shows that the title complex has a binuclear structure and crystallized in a monoclinic P21/c space group. As shown in figure, the central atom Cu(II) is coordinated with two Cl ions (Cl1, and Cl2) and three N atoms (N1, N6i and N7 from three tmbt ligands, respectively). The Cu–Cl and Cu–N bonds around Cu1 are of length: Cu1–Cl1: 2.2616(12) Å; Cu1–Cl2: 2.3291(12) Å; Cu1–N1: 2.127(3) Å; Cu1–N6i: 2.008(3) Å; Cu1–N7:2.185(4) Å. The range of bond angles around the metal center Cu(II) is 88.23(10)°–130.93(11)°. In each tmbt ligand, the angle between the benzotriazole ring and the triazole ring is 71.973(137)° and 72.026(116)°, the distance between the benzotriazole rings in two adjacent monodentate coordinated tmbt ligands is 3.982 Å, so it can be inferred that there may be one kind of π–π conjugation between the two adjacent molecules, which makes the centrosymmetric unit extend into a more stable one-dimensional chain structure.

Corresponding author: Hanbing Li, Henan University of Chinese Medicine, Zhengzhou, 450046, P.R. China, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest: The authors declare no conflicts of interest regarding this article.

References

1. Sheldrick, G. M. A Short History of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Search in Google Scholar PubMed

2. Katritzky, A.-R.; Drewniak-Deyrup, M.; Lan, X.-F.; Brunner, F. Chemistry of Benzotriazole. Preparation, Lithiation and Transformation of N-(Benzotriazol-1-ylmethyl) Heterocycles. J. Heterocycl. Chem. 1989, 26, 829–836; https://doi.org/10.1002/jhet.5570260359.Search in Google Scholar

3. Altamimi, M.; Syed, S. A.; Tuzun, B.; Alhazani, M. R.; Alnemer, O.; Bari, A. Synthesis Biological Evaluation and Molecular Docking of Isatin Hybrids as Anti-cancer and Anti-microbial Agents. J. Enzyme Inhib. Med. Chem. 2024, 39, 2288548; https://doi.org/10.1080/14756366.2023.2288548.Search in Google Scholar PubMed

4. Zhou, M.; Duan, X.; Jin, T.; Feng, X.; Liu, Y.; Wang, S.; Feng, J.; Zhang, M.; Chai, T.; Mao, B.; Shao, S.; Jin, G. Design, Synthesis, and Antitumor Activity Evaluation of BF3-O, M, P-Phenylenediamine Bridged with Pyrimidine-Indole BF3 Adduction Derivatives. Mol. Divers. 2024, 7; https://doi.org/10.1007/s11030-024-10863-3.Search in Google Scholar PubMed

5. Singh, A.; Beg, M. A.; Jamal, S.; Khan, A.; Rahman, A.; Selvapandiyan, A.; Shafi, S.; Hoda, N. Robust Leishmanicidal Upshot of Some New Diphenyl Triazine-Based Molecules. RSC Adv. 2024, 14, 22587–22597; https://doi.org/10.1039/d4ra01904k.Search in Google Scholar PubMed PubMed Central

6. Murcia-Galán, R. A.; Durán, S. M.; Leal-Pinto, S. M.; Roa-Cordero, M. V.; Vargas, J. D.; Herrera, L. V.; Muñoz-Castro, A.; MacLeod-Carey, D.; Naranjo, T. W.; Rodríguez-Kessler, P. L.; Hurtado, J. J. Antifungal Activity of Co(II) and Cu(II) Complexes Containing 1,3-Bis(benzotriazol-1-Yl)-Propan-2-Ol on the Growth and Virulence Traits of Fluconazole-Resistant Candida Species: Synthesis, DFT Calculations, and Biological Activity. BMC Chem. 2023, 17, 135; https://doi.org/10.1186/s13065-023-01037-7.Search in Google Scholar PubMed PubMed Central

7. Czylkowska, A.; Pitucha, M.; Lanka, S.; Raducka, A.; Rogalewicz, B.; Szczesio, M.; Swiatkowski, M.; Zarczynski, A.; Klepacz-Smółka, A.; Szczytko, J.; Camargo, B.; Drabinska, A.; Szymanski, P. Triazole-based Mn(II), Fe(II), Ni(II), Cu(II) and Zn(II) Complexes as Potential Anticancer Agents – Physicochemical Properties, In Silico Predictions and In Vitro Activity. Polyhedron 2024, 261, 117106; https://doi.org/10.1016/j.poly.2024.117106.Search in Google Scholar

8. Zhao, W. L. Reproductive Toxicity of 7,8-Dihydroxyflavone-Copper Metal Complexes in Mice. Master’s Thesis, Guangzhou Univ. Chin. Med., Guangzhou, China, 2021.Search in Google Scholar
Received: 2024-07-29
Accepted: 2024-10-04
Published Online: 2024-10-21
Published in Print: 2024-12-17

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 3-nitrophenol-2,1,3-benzoselenadiazole (1/1), C12H9N3O3Se
  4. Crystal structure of diaqua-(hydroxido)-{μ-[2-(hydroxy)-5-[(4-nitrophenyl)diazenyl]benzoato]}-{2-hydroxy-5-[(4-nitrophenyl)diazenyl]benzoato}-(1,10-phenanthroline)-diterbium hydrate, C38H27.4N8O12.2Tb
  5. Crystal structure of poly[bis(μ3-3-fluoro-4-(1H-1,2,4-triazol-1-yl)benzoato-κ3 O:O′:N)cadmium(II)] – dimethylformamide (1/1), C21H17CdF2N7O5
  6. The crystal structure of 2-amino-N-(pyridin-2-yl)benzamide, C12H11N3O
  7. The crystal structure of 2,3-di(pyridin-2-yl)-2,3-dihydroquinazolin-4(1H)-one, C18H14N4O
  8. Crystal structure of 2-chloro-4-fluorobenzyl (R)-2-(6-methoxynaphthalen-2-yl)propanoate, C21H18ClFO3
  9. Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid]-(methylsulfinyl)methane, C15H16N2O6S
  10. The crystal structure of 2-ethyl-1,1-dimethyl-1H-benzo[e]indole, C16H17N
  11. The crystal structure of (Z)-5-amino-N ′-hydroxy-1H-pyrazole-4-carboximidamide, C4H7N5O
  12. The crystal structure of 2,2,5-trimethyl-3-(4-(4-(5-phenyl-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)phenyl)imidazolidin-4-one, C24H24N4O2S
  13. The crystal structure of tetrakis(μ2-acetato-κ2 O:O′)-bis[(4′-phenyl-4,2′:6′,4″-terpyridine-κ1 N)dicopper(II)], C25H21CuN3O4
  14. Crystal structure of poly(3-thiophenecarboxylato-κ 3 O,O′:O′)-(methanol-κO)cadmium(II), C11H10O5S2Cd
  15. The crystal structure of dichloridobis[4′-(p-methoxylphenyl)-4,2′:6′,4″-terpyridine-κN] zinc(II), C44H34Cl2N6O2Zn
  16. The crystal structure of 1-(2-carboxyethyl)-1H-imidazole 3-oxide
  17. Crystal structure of 1,1′,1″-(nitrilotris(ethane-2,1-diyl))tris(3-(4-(((E)-pyridin-2-ylmethylene)amino)phenyl)urea), C45H47N13O4
  18. Crystal structure of a (E)-4-bromo-N-(4-(diethylamino)-2-hydroxybenzylidene) benzenaminium acetate ─ 4-bromoaniline (1/1)
  19. Crystal structure of 2,2′-(iminobis(methylene))bis(benzimidazolium) bis(p-toluenesulfonate), C30H31N5O6S2
  20. The crystal structure of alogliptinium meta-chlorobenzoate
  21. Crystal structure of 4-bromobenzyl 2-(6-methoxy-naphthalen-2-yl)propanoate, C21H19BrO3
  22. The hydrated double salt structure of (E)-4-(2-benzylidenehydrazine-1-carbonyl)pyridin-1-ium cation with 2-hydroxybenzoate and benzoate anions
  23. Crystal structure of (R)(R)-5-chloro-3-((S,1E,3E)-3,5-dimethyl-hepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2,6,7,8-tetrahydroisoquinolin-7-yl acetate, C21H24ClNO4
  24. The crystal structure of bis(3-oxo-1,3-diphenylprop-1-en-1-olato-κ 2 O:O′)-bis(1,4-dioxane-κ 1 O)nickel(II), C38H38O8Ni
  25. Crystal structure of poly[aqua-(pyridine-3-carboxylato-κ1 N)(pyridine-3-carboxylato-κ2 O,O′) cadmium(II)] dihydrate, C12H14N2O7Cd
  26. The crystal structure of 4-(4-phenyl-5-(((1-(2,4,6-tribromophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-4H-1,2,4-triazol-3-yl)pyridine, C22H14Br3N7S
  27. The crystal structure of N-benzylquinoline-2-carbothioamide, C17H14N2S
  28. Crystal structure of bis(3-isopropylphenyl)-4,4′-bipyridinium dichloride dihydrate, C28H30N2⋅2Cl⋅2H2O
  29. The crystal structure of ethyl 2-amino-4-(cyanophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C19H18N2O4
  30. Crystal structure of (4R,10S)-6-hydroxy-7-isopropyl-4,10-dimethyl-1,2,3,5-hexahydro-6,10-epoxyazulen-9-one, C15H22O3
  31. The crystal structure of (E)-(2-(2-hydroxy-3-methoxybenzylidene)aminophenyl)arsonic acid, C14H14AsNO5
  32. The crystal structure of poly[(μ 2-2-aminoisophthalato-κ4O,O′:O″:O″′)-(N-methylpyrrolidone κ1O)-dioxido-uranium(VI)], C13H14N2O7U
  33. The crystal structure of the co-crystal isonicotinamide · terephthalic acid, C8H6O4·2(C6H6N2O)
  34. The crystal structure of (E)-1-phenyl-3-(p-tolylthio)but-2-en-1-one, C17H16OS
  35. The crystal structure of 4,5-bis((Z)-chloro(hydroxyimino)methyl)-1H-imidazol-3-ium chloride monohydrate
  36. The crystal structure of 1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-dione. C18H20N2O2
  37. Crystal structure of 2-chloro-4-fluorobenzyl 2-acetoxybenzoate, C16H12ClFO4
  38. Crystal structure of methyl 1-phenyl-9H-pyrido[3,4-b]indole-3-carboxylate, C19H14N2O2
  39. Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl)(5-fluoro-2-iodophenyl)methanone, C19H17FINO4
  40. Crystal structure of tetrachlorido-bis(1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2 N:N′)dicopper, C36H32Cu2N24Cl4
  41. Crystal structure of 2-(2,3-bis(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoxalin-1-yl)anilin, C30H24N4O2
  42. Crystal structure of 5,7-dihydroxy-2-phenyl-4H-chromen-4-one–N,N-dimethylformamide(1/1), C18H17NO5
  43. The crystal structure of bis(μ 2-biphenyl-2,2′-dicarboxylato)-diaqua-bis(nitrato)-bis(2,2′:6′,2′′-terpyridine)dineodymium(III), C46H32I2N8Nd2O16
  44. Crystal structure of (Z)-4-amino-N ′-((4-chlorophenyl)(phenyl)methylene)benzohydrazide, C20H16ClN3O
  45. Crystal structure of (E)-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5(2H)-one, C23H25NO5
  46. Crystal structure of (R)-2-((3-(3-aminopiperidin-1-yl)-6-methyl-5-oxo-1,2,4-triazin-4(5H)-yl) methyl)-4-fluorobenzonitrile benzoate monohydrate, C24H27FN6O4
  47. The crystal structure of [triaqua-(8-carboxymethoxy-quinoline-2-carboxylato-κ 3 N,O,O)copper(II)]monohydrate, C12H15NO9Cu
  48. Crystal structure of (((4-chlorophenyl)sulfonyl)glycinato-κ 2 N,O)bis(1,10-phenanthroline-κ 2 N,N′)cobalt(II) tetrahydrate, C32H30ClCoN5O8S
  49. Crystal structure of (((3-nitrophenyl)sulfonyl)-β-alaninato-κO)bis(2,2′-bipyridine-κ 2 N, N′)copper(II) 3-nitrobenzenesulfonate, C35H29CuN7O11S2
  50. Crystal structure of 3-phenoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C27H24O4
  51. 6-(2′,3′-Dihydroxy-3′-methylbutyl)-7-methoxy-8-(3″-methylbut-2″-en-1″-yl)-2H-chromen-2-one, C20H26O5
  52. Crystal structure of bromido-(2,2′:6′,2″-terpyridine-4′-onato-κ3N)palladium(II) methanol solvate
  53. The crystal structure of ethyl 2-amino-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C20H22N2O6
  54. Crystal structure of (1E,3E,5E)-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C28H36O2
  55. The crystal structure of tris(2-bromo-4-methylphenyl)amine, C21H18Br3N
  56. The crystal structure of 3-(2,5-dimethylanilino)-1-(2,5-dimethylphenyl)-4-methyl-1H-pyrrole-2,5-dione, C21H22N2O2
  57. Crystal structure of dicarbonyl (μ2-indole-2-carboxylato κ2 O:O′)tris(triphenylarsine-κAs)dirhodium(I) acetone solvate, C68H56As3NO5Rh2
  58. The crystal structure of 4-chloro-2-formylphenyl 4-methylbenzenesulfonate, C14H11ClO4S
  59. Crystal structure of 4-iodobenzyl 2-(6-methoxynaphthalen-2-yl) propanoate, C21H19IO3
https://doi.org/10.1515/ncrs-2024-0322
Creative Commons
BY 4.0

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 3-nitrophenol-2,1,3-benzoselenadiazole (1/1), C12H9N3O3Se
  4. Crystal structure of diaqua-(hydroxido)-{μ-[2-(hydroxy)-5-[(4-nitrophenyl)diazenyl]benzoato]}-{2-hydroxy-5-[(4-nitrophenyl)diazenyl]benzoato}-(1,10-phenanthroline)-diterbium hydrate, C38H27.4N8O12.2Tb
  5. Crystal structure of poly[bis(μ3-3-fluoro-4-(1H-1,2,4-triazol-1-yl)benzoato-κ3 O:O′:N)cadmium(II)] – dimethylformamide (1/1), C21H17CdF2N7O5
  6. The crystal structure of 2-amino-N-(pyridin-2-yl)benzamide, C12H11N3O
  7. The crystal structure of 2,3-di(pyridin-2-yl)-2,3-dihydroquinazolin-4(1H)-one, C18H14N4O
  8. Crystal structure of 2-chloro-4-fluorobenzyl (R)-2-(6-methoxynaphthalen-2-yl)propanoate, C21H18ClFO3
  9. Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid]-(methylsulfinyl)methane, C15H16N2O6S
  10. The crystal structure of 2-ethyl-1,1-dimethyl-1H-benzo[e]indole, C16H17N
  11. The crystal structure of (Z)-5-amino-N ′-hydroxy-1H-pyrazole-4-carboximidamide, C4H7N5O
  12. The crystal structure of 2,2,5-trimethyl-3-(4-(4-(5-phenyl-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)phenyl)imidazolidin-4-one, C24H24N4O2S
  13. The crystal structure of tetrakis(μ2-acetato-κ2 O:O′)-bis[(4′-phenyl-4,2′:6′,4″-terpyridine-κ1 N)dicopper(II)], C25H21CuN3O4
  14. Crystal structure of poly(3-thiophenecarboxylato-κ 3 O,O′:O′)-(methanol-κO)cadmium(II), C11H10O5S2Cd
  15. The crystal structure of dichloridobis[4′-(p-methoxylphenyl)-4,2′:6′,4″-terpyridine-κN] zinc(II), C44H34Cl2N6O2Zn
  16. The crystal structure of 1-(2-carboxyethyl)-1H-imidazole 3-oxide
  17. Crystal structure of 1,1′,1″-(nitrilotris(ethane-2,1-diyl))tris(3-(4-(((E)-pyridin-2-ylmethylene)amino)phenyl)urea), C45H47N13O4
  18. Crystal structure of a (E)-4-bromo-N-(4-(diethylamino)-2-hydroxybenzylidene) benzenaminium acetate ─ 4-bromoaniline (1/1)
  19. Crystal structure of 2,2′-(iminobis(methylene))bis(benzimidazolium) bis(p-toluenesulfonate), C30H31N5O6S2
  20. The crystal structure of alogliptinium meta-chlorobenzoate
  21. Crystal structure of 4-bromobenzyl 2-(6-methoxy-naphthalen-2-yl)propanoate, C21H19BrO3
  22. The hydrated double salt structure of (E)-4-(2-benzylidenehydrazine-1-carbonyl)pyridin-1-ium cation with 2-hydroxybenzoate and benzoate anions
  23. Crystal structure of (R)(R)-5-chloro-3-((S,1E,3E)-3,5-dimethyl-hepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2,6,7,8-tetrahydroisoquinolin-7-yl acetate, C21H24ClNO4
  24. The crystal structure of bis(3-oxo-1,3-diphenylprop-1-en-1-olato-κ 2 O:O′)-bis(1,4-dioxane-κ 1 O)nickel(II), C38H38O8Ni
  25. Crystal structure of poly[aqua-(pyridine-3-carboxylato-κ1 N)(pyridine-3-carboxylato-κ2 O,O′) cadmium(II)] dihydrate, C12H14N2O7Cd
  26. The crystal structure of 4-(4-phenyl-5-(((1-(2,4,6-tribromophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-4H-1,2,4-triazol-3-yl)pyridine, C22H14Br3N7S
  27. The crystal structure of N-benzylquinoline-2-carbothioamide, C17H14N2S
  28. Crystal structure of bis(3-isopropylphenyl)-4,4′-bipyridinium dichloride dihydrate, C28H30N2⋅2Cl⋅2H2O
  29. The crystal structure of ethyl 2-amino-4-(cyanophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C19H18N2O4
  30. Crystal structure of (4R,10S)-6-hydroxy-7-isopropyl-4,10-dimethyl-1,2,3,5-hexahydro-6,10-epoxyazulen-9-one, C15H22O3
  31. The crystal structure of (E)-(2-(2-hydroxy-3-methoxybenzylidene)aminophenyl)arsonic acid, C14H14AsNO5
  32. The crystal structure of poly[(μ 2-2-aminoisophthalato-κ4O,O′:O″:O″′)-(N-methylpyrrolidone κ1O)-dioxido-uranium(VI)], C13H14N2O7U
  33. The crystal structure of the co-crystal isonicotinamide · terephthalic acid, C8H6O4·2(C6H6N2O)
  34. The crystal structure of (E)-1-phenyl-3-(p-tolylthio)but-2-en-1-one, C17H16OS
  35. The crystal structure of 4,5-bis((Z)-chloro(hydroxyimino)methyl)-1H-imidazol-3-ium chloride monohydrate
  36. The crystal structure of 1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-dione. C18H20N2O2
  37. Crystal structure of 2-chloro-4-fluorobenzyl 2-acetoxybenzoate, C16H12ClFO4
  38. Crystal structure of methyl 1-phenyl-9H-pyrido[3,4-b]indole-3-carboxylate, C19H14N2O2
  39. Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl)(5-fluoro-2-iodophenyl)methanone, C19H17FINO4
  40. Crystal structure of tetrachlorido-bis(1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2 N:N′)dicopper, C36H32Cu2N24Cl4
  41. Crystal structure of 2-(2,3-bis(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoxalin-1-yl)anilin, C30H24N4O2
  42. Crystal structure of 5,7-dihydroxy-2-phenyl-4H-chromen-4-one–N,N-dimethylformamide(1/1), C18H17NO5
  43. The crystal structure of bis(μ 2-biphenyl-2,2′-dicarboxylato)-diaqua-bis(nitrato)-bis(2,2′:6′,2′′-terpyridine)dineodymium(III), C46H32I2N8Nd2O16
  44. Crystal structure of (Z)-4-amino-N ′-((4-chlorophenyl)(phenyl)methylene)benzohydrazide, C20H16ClN3O
  45. Crystal structure of (E)-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5(2H)-one, C23H25NO5
  46. Crystal structure of (R)-2-((3-(3-aminopiperidin-1-yl)-6-methyl-5-oxo-1,2,4-triazin-4(5H)-yl) methyl)-4-fluorobenzonitrile benzoate monohydrate, C24H27FN6O4
  47. The crystal structure of [triaqua-(8-carboxymethoxy-quinoline-2-carboxylato-κ 3 N,O,O)copper(II)]monohydrate, C12H15NO9Cu
  48. Crystal structure of (((4-chlorophenyl)sulfonyl)glycinato-κ 2 N,O)bis(1,10-phenanthroline-κ 2 N,N′)cobalt(II) tetrahydrate, C32H30ClCoN5O8S
  49. Crystal structure of (((3-nitrophenyl)sulfonyl)-β-alaninato-κO)bis(2,2′-bipyridine-κ 2 N, N′)copper(II) 3-nitrobenzenesulfonate, C35H29CuN7O11S2
  50. Crystal structure of 3-phenoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C27H24O4
  51. 6-(2′,3′-Dihydroxy-3′-methylbutyl)-7-methoxy-8-(3″-methylbut-2″-en-1″-yl)-2H-chromen-2-one, C20H26O5
  52. Crystal structure of bromido-(2,2′:6′,2″-terpyridine-4′-onato-κ3N)palladium(II) methanol solvate
  53. The crystal structure of ethyl 2-amino-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C20H22N2O6
  54. Crystal structure of (1E,3E,5E)-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C28H36O2
  55. The crystal structure of tris(2-bromo-4-methylphenyl)amine, C21H18Br3N
  56. The crystal structure of 3-(2,5-dimethylanilino)-1-(2,5-dimethylphenyl)-4-methyl-1H-pyrrole-2,5-dione, C21H22N2O2
  57. Crystal structure of dicarbonyl (μ2-indole-2-carboxylato κ2 O:O′)tris(triphenylarsine-κAs)dirhodium(I) acetone solvate, C68H56As3NO5Rh2
  58. The crystal structure of 4-chloro-2-formylphenyl 4-methylbenzenesulfonate, C14H11ClO4S
  59. Crystal structure of 4-iodobenzyl 2-(6-methoxynaphthalen-2-yl) propanoate, C21H19IO3
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 8.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2024-0322/html
Scroll to top button